Pharmacologic Inhibition of STK19 Impairs NRAS-Driven Melanoma.

Pharmacologic Inhibition of STK19 Impairs NRAS-Driven Melanoma.

Publication date: Feb 08, 2019

Phosphorylation of oncogenic NRAS by STK19 promotes melanomagenesis.

___. Pharmacologic Inhibition of STK19 Impairs NRAS-Driven Melanoma. 21648. 2019 Cancer Discov.



Please signin to view all article content and metadata.


Leave a Comment